ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
8.14
+0.09 (1.12%)
Apr 13, 2026, 2:53 PM EDT - Market open
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $808.28 million as of April 13, 2026. Its market cap has decreased by -34.62% in one year.
Market Cap
808.28M
Enterprise Value
726.84M
1-Year Change
-34.62%
Ranking
Category
Stock Price
$8.14
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $808.28M, an increase of 42.24%. That is a compound annual growth rate of 10.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 799.34M | -30.59% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 841.91M |
| Vor Biopharma | 838.25M |
| Omeros | 827.24M |
| Sana Biotechnology | 824.62M |
| Bright Minds Biosciences | 818.66M |
| Arbutus Biopharma | 811.23M |
| MannKind | 793.61M |
| Maravai LifeSciences Holdings | 789.20M |